{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:32:01Z","timestamp":1790890321682,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T00:00:00Z","timestamp":1546905600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12889-018-6320-x","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T11:24:07Z","timestamp":1546946647000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Risk factors of hepatitis B virus surface antigen carriage and serological profile of HBsAg carriers in Lom\u00e9 Togo, 2016"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6899-2884","authenticated-orcid":false,"given":"Wemboo Afiwa","family":"Halatoko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akouda","family":"Patassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Yanogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leou Ismael","family":"Banla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adjaho","family":"Koba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoulkaneiri","family":"Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koffi","family":"Akolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agballa M\u00e9biny-Esso","family":"Tchalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamadi","family":"Assane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aboukerim","family":"Naba-Mouchedou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Sawadogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon Nouvura","family":"Antara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kossi","family":"Badziklou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abiba Kere","family":"Banla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier Koumavi","family":"Ekouevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idrissa","family":"Sanou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,8]]},"reference":[{"key":"6320_CR1","volume-title":"Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection","author":"WHO","year":"2015","unstructured":"WHO. Guidelines Approved by the Guidelines Review Committee. In: Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection. Geneva: World Health Organization; 2015."},{"key":"6320_CR2","unstructured":"World Health Organization. Global Health Sector Strategies on Viral Hepatitis 2016-2021. 2016. p. 13. Avialable on \n                    http:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA69\/A69_32-en.pdf?ua=1\n                    \n                  ."},{"key":"6320_CR3","unstructured":"Finding the missing millions the world hepatitis alliance\u2019s 2018 \u2013 2020 strategic plan available on \n                    http:\/\/www.worldhepatitisalliance.org\n                    \n                  ."},{"issue":"9859","key":"6320_CR4","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","volume":"380","author":"R Lozano","year":"2012","unstructured":"Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2095\u2013128.","journal-title":"Lancet"},{"key":"6320_CR5","volume-title":"Global Burden of Disease","author":"IHME","year":"2017","unstructured":"IHME. Global burden of disease and WHO\/UNAIDS estimates. In: Global Burden of Disease; 2017."},{"key":"6320_CR6","doi-asserted-by":"publisher","unstructured":"The Polaris Observatory Collaborators. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol 2018, Published Online March 26, 2018. \n                    https:\/\/doi.org\/10.1016\/S2468-1253(18)30056-6\n                    \n                  .","DOI":"10.1016\/S2468-1253(18)30056-6"},{"key":"6320_CR7","first-page":"405","volume-title":"World Health Organization","author":"WHO","year":"2009","unstructured":"WHO. Weekly epidemiological record. In: World Health Organization, vol. vol. 40; 2009. p. 405\u201320."},{"issue":"1","key":"6320_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ijid.2008.03.015","volume":"13","author":"L Chen","year":"2009","unstructured":"Chen L, Liu F, Fan X, Gao J, Chen N, Wong T, Wu J, Wen SW. Detection of hepatitis B surface antigen, hepatitis B core antigen, and hepatitis B virus DNA in parotid tissues. Int J Infect Dis. 2009;13(1):20\u20133.","journal-title":"Int J Infect Dis"},{"key":"6320_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14205\/2310-9386.2015.03.01.1","volume":"3","author":"AKGK Banla","year":"2015","unstructured":"Banla AKGK, Halatoko WA, Layibo Y, Akolly K, Maman I, Tamekloe TA, Feteke L, Vovor A, Pitche P. Prevalence of the surface antigen of hepatitis B virus among youth aged 15 to 24 in TOGO in 2010. J Infec Dis Ther. 2015;3:1\u20135.","journal-title":"J Infec Dis Ther"},{"key":"6320_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1874357901710011001","volume":"11","author":"M Kolou","year":"2017","unstructured":"Kolou M, Katawa G, Salou M, Gozo-Akakpo KS, Dossim S, Kwarteng A, Prince-David M. High prevalence of hepatitis B virus infection in the age range of 20-39 years old individuals in Lome. Open Virol J. 2017;11:1\u20137.","journal-title":"Open Virol J"},{"key":"6320_CR11","volume-title":"Prevalence of Hepatitis B among Students from the University of Lom\u00e9, Togo in 2015","author":"D Ekouevi","year":"2017","unstructured":"Ekouevi D, Thomas A, Sewu D, Lawson-Ananissoh L, Bk T, Salou M, Ketoh G, David M, Coffie P, Redah D. Prevalence of Hepatitis B among Students from the University of Lom\u00e9, Togo in 2015, vol. vol. 07; 2017."},{"key":"6320_CR12","unstructured":"Minist\u00e8re de la Sant\u00e9 du Togo. Programme Elargi de Vaccination du Togo, Rapport d\u2019activit\u00e9s de l\u2019ann\u00e9e 2009. 2010 p. 7"},{"key":"6320_CR13","doi-asserted-by":"crossref","unstructured":"Breakwell L, Tevi-Benissan C, Childs L, Mihigo R, Tohme R: The status of hepatitis B control in the African region. 2017(1937\u20138688 (Electronic)).","DOI":"10.11604\/pamj.supp.2017.27.3.11981"},{"key":"6320_CR14","doi-asserted-by":"crossref","unstructured":"Espert L1, Degols G, Gongora C, Blondel D, Williams BR, Silverman RH, Mechti N. SG20, A new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA genomic viruses. J Biol Chem. 2003;278(18):16151\u20138.","DOI":"10.1074\/jbc.M209628200"},{"key":"6320_CR15","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.scitotenv.2010.09.036","volume":"423","author":"BJ Hennig","year":"2012","unstructured":"Hennig BJ, Hall AJ. Host genetic factors in hepatitis B infection, liver cancer and vaccination response: a review with a focus on Africa. Sci Total Environ. 2012;423:202\u20139.","journal-title":"Sci Total Environ"},{"issue":"6","key":"6320_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.4103\/1755-6783.162635","volume":"8","author":"A Olalekan","year":"2015","unstructured":"Olalekan A. Prevalence and risk factors for hepatitis B and C among sexually active undergraduates in southwestern Nigeria. Ann Trop Med Public Health. 2015;8(6):235\u201340.","journal-title":"Ann Trop Med Public Health"},{"issue":"3","key":"6320_CR17","doi-asserted-by":"publisher","first-page":"709","DOI":"10.4314\/ahs.v15i3.2","volume":"15","author":"R Ephraim","year":"2015","unstructured":"Ephraim R, Donko I, Sakyi SA, Ampong J, Agbodjakey H. Seroprevalence and risk factors of hepatitis B and hepatitis C infections among pregnant women in the Asante Akim north municipality of the Ashanti region, Ghana; a cross sectional study. Afr Health Sci. 2015;15(3):709\u201313.","journal-title":"Afr Health Sci"},{"issue":"3","key":"6320_CR18","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/hep.23190","volume":"50","author":"AS Lok","year":"2009","unstructured":"Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50(3):661\u20132.","journal-title":"Hepatology"},{"key":"6320_CR19","unstructured":"Patassi A A, Kotosso A, Salou M, Bawe LD, Krivine A, Ephrem M, et al. Prevalence des marqueurs du virus de l\u2019hepatite B chez les patients infectes par le VIH et traites par anti-retroviraux dans un pays a ressources limitees. J Rech Sci Univ Lom\u00e9. 2015;17(3):685\u201392."},{"key":"6320_CR20","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1186\/1471-2458-8-416","volume":"8","author":"TJ Nagu","year":"2008","unstructured":"Nagu TJ, Bakari M, Matee M. Hepatitis A, B and C viral co-infections among HIV-infected adults presenting for care and treatment at Muhimbili National Hospital in Dar Es Salaam. Tanzania BMC public health. 2008;8:416.","journal-title":"Tanzania BMC public health"},{"issue":"1","key":"6320_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12981-017-0136-0","volume":"14","author":"G Gachara","year":"2017","unstructured":"Gachara G, Magoro T, Mavhandu L, Lum E, Kimbi HK, Ndip RN, Bessong PO. Characterization of occult hepatitis B virus infection among HIV positive patients in Cameroon. AIDS Res Ther. 2017;14(1):11.","journal-title":"AIDS Res Ther"},{"issue":"3","key":"6320_CR22","doi-asserted-by":"publisher","first-page":"677","DOI":"10.4314\/ahs.v16i3.6","volume":"16","author":"SA Hudu","year":"2016","unstructured":"Hudu SA, Harmal NS, Saeed MI, Alshrari AS, Malik YA, Niazlin MT, Hassan R, Sekawi Z. Molecular and serological detection of occult hepatitis B virus among healthy hepatitis B surface antigen-negative blood donors in Malaysia. Afr Health Sci. 2016;16(3):677\u201383.","journal-title":"Afr Health Sci"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-018-6320-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-018-6320-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-018-6320-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T19:05:09Z","timestamp":1578423909000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-018-6320-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,8]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["6320"],"URL":"https:\/\/doi.org\/10.1186\/s12889-018-6320-x","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,8]]},"assertion":[{"value":"25 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We used an existing database build with the approval of the INH internal ethics council. Prior to the exploitation of the database, we obtained an authorization from the Institut National d\u2019Hygi\u00e8ne of Lom\u00e9. People who participated to the free campaign gave a written consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Non-applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"32"}}